By Iris Kulbatski — 2020
Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.
Read on www.discovermagazine.com
CLEAR ALL
María Sabina was well-respected in the village as a healer and shaman. She’d been consuming psilocybin mushrooms regularly since she was seven years old, and had performed the velada mushroom ceremony for over 30 years before Wasson arrived.
The last time I was on ketamine, I was hooked up to an IV following surgery. This time, the drug—in general medical use as an anesthetic since 1970—arrived on my doorstep courtesy of Mindbloom, a new telemedicine company specializing in ketamine-based psychedelic therapy.
1
The benefits of controlled psilocybin use and spiritual practice on people's well-being long outlast the high, researchers find.
Microdosing psilocybin mushrooms can lead to a psychedelic healing experience. The mushroom user can revisit trauma and find new insights.
Research into psychedelics, shut down for decades, is now yielding exciting results.
2
Scott Atkinson says magic mushrooms have already done much to tame the post-traumatic stress demons conjured by two years serving in Afghanistan and Bosnia.
Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.
Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.
My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.